ASSTON PHARMACEUTICALS LIMITED IPO
ASSTON PHARMACEUTICALS LIMITED was a SME IPO, offered at ₹115–₹123 per share. The issue was subscribed 173.53× overall (QIBs 85.76×, NIIs 261.67×, retail 172.13×). It listed on 16 Jul 2025 at ₹119 and closed its first day at ₹125, a listing gain of +1.6% versus the ₹123 issue price. It now trades around ₹151 (+22.5% versus the issue price).
Frequently asked questions
- How many times was the ASSTON PHARMACEUTICALS LIMITED IPO subscribed?
- The ASSTON PHARMACEUTICALS LIMITED IPO was subscribed 173.53× overall — 85.76× in the QIB category, 261.67× among non-institutional investors, 172.13× in retail.
- What were the ASSTON PHARMACEUTICALS LIMITED IPO listing gains?
- ASSTON PHARMACEUTICALS LIMITED listed on 16 Jul 2025 at ₹119, closing its first day at ₹125 — a listing gain of +1.6% versus the ₹123 issue price.
- What were the retail allotment odds for the ASSTON PHARMACEUTICALS LIMITED IPO?
- Retail was subscribed 172.13×, so a single-lot application had roughly a 0.6% chance of allotment (about 1 in 172), and allotment was finalised on 14 Jul 2025.
- What was the price band and lot size of the ASSTON PHARMACEUTICALS LIMITED IPO?
- The price band was ₹115–₹123 per share.